Advancing therapies
for rare disease patients
SHRARE transforms unexploited research into ready-to-license rare disease therapies, connecting the world of science with the world of patients.
For Researchers
We back your science. We help bring it to life.
- IP protection & regulatory strategy
- Financial models & R&D roadmaps
- Global pharma connections
AI-Powered PlatformHow we transform research into therapies
For Life Science Players
License faster. Execute better. Increase ROI.
- De-risked, clinical-stage assets
- Streamlined due diligence
- Exclusive early access pipeline
The Rare Disease Reality
The scale of rarity, the promise of speed: breakthroughs to patients.
0M
patients in USA
0M
patients in Europe
The Hidden Scale of Rare Cancer
Rare Cancer Research Can't Wait!
SHRARE researchers will strive to contribute
to accelerate the development of rare cancer therapies
RARE CANCERS are DEFINED as:
<0K
cases per year for each rare cancer
0%
of all cancers are rare
0%
of all cancer deaths
The SHRARE Solution
RESEARCH
TRANSFORM
LICENSE
SHRARE transforms unexploited research into ready-to-license rare disease therapies through augmented intelligence, connecting researchers and Life Science players to get treatments to patients faster
Ready to accelerate rare disease research?
Involved in Research?
Turn your research into real-world impact
Looking for licencing in?
License faster, execute better, increase ROI